New Poll Suggests Ted Cruz Could Lose His Re-Election Bid in November

Democrats are looking to gain two seats in the U.S. Senate this November in order to finally gain a majority in that chamber. And it looks like the traditionally red Texas may be one of the places they could target thanks to Ted Cruz.

A new poll found that Cruz is only leading his Democratic challenger Beto O'Rourke by six percentage points. 49 percent of voters said they would vote for Cruz, with 43 percent saying they support O'Rourke and another six percent saying they're undecided. To put that in perspective, the same poll back in May showed Cruz with an 11-point lead, which means he's lost about five percent of support in just over two months.

Of course, this doesn't mean we should assume Cruz should start packing his bags. But it does indicate his level of support is dropping, and if O'Rourke can continue his momentum, he could make it a competitive race.

Making Texas competitive would be huge new for Democrats. Despite major anti-Trump sentiment in America right now, there aren't many vulnerable incumbent Republicans in the Senate. But making Cruz sweat in Texas would also indicate other Republicans in less conservative states are vulnerable as well.

It should be noted that O'Rourke has also incorporated marijuana into his campaign. He supports legalizing marijuana, and has even appeared at events alongside legendary stoner Willie Nelson, another Texas native.

(h/t MSNBC)

Latest.

As medical marijuana continues to gain ground across the US, more and more colleges are adding cannabis to their curriculum. In fact, more than half of America's pharmaceutical schools (62 percent) now teach students about medical marijuana according to a new survey conducted by researchers from the University of Pittsburgh's School of Pharmacy. "With more states legalizing medical marijuana, student pharmacists must be prepared to effectively care for their patients who may use medical marijuana alone or in combination with prescription or over-the-counter medications," the study's authors wrote.